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Abstract
Eviction or destabilization of nucleosomes from chromatin is a hallmark of functional regulatory
elements of the eukaryotic genome. Historically identified by nuclease hypersensitivity, these
regulatory elements are typically bound by transcription factors or other regulatory proteins.
FAIRE (Formaldehyde-Assisted Isolation of Regulatory Elements) is an alternative approach to
identify these genomic regions and has proven successful in a multitude of eukaryotic cell and
tissue types. Cells or dissociated tissues are crosslinked briefly with formaldehyde, lysed, and
sonicated. Sheared chromatin is subjected to phenol-chloroform extraction and the isolated DNA,
typically encompassing 1–3% of the human genome, is purified. We provide guidelines for
quantitative analysis by PCR, microarrays, or next-generation sequencing. Regulatory elements
enriched by FAIRE display high concordance with those identified by nuclease hypersensitivity or
ChIP, and the entire procedure can be completed in three days. FAIRE exhibits low technical
variability, which allows its use in large-scale studies of chromatin from normal or diseased
tissues.
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Understanding the regulation of transcription by sequence-specific regulatory factors and
subsequent remodeling of chromatin is central to studies of health and disease. The activities
of regulatory factors at promoters, enhancers, silencers, and insulators typically cause
nucleosomes to be evicted from chromatin in eukaryotic cells1. Therefore, one of the most
effective means of discovering transcriptional regulatory elements is through the
identification of nucleosome-depleted regions (“open chromatin”). Historically, this was
accomplished by exploiting regional hypersensitivity to nucleases such as DNase I2–9. More
recently, we demonstrated an alternative methodology for the detection of open chromatin,
which we termed FAIRE (Formaldehyde-Assisted Isolation of Regulatory Elements)10–13.
FAIRE was first characterized in yeast and subsequently applied to human cells and
tissues13–16. The technique has proven useful for a wide range of eukaryotes, from
Plasmodium17 to maize18. Here, we present recent methodological enhancements that
improve the utility and reliability of FAIRE, especially for use on tissues or lipid-laden cells
such as adipocytes.
Overview
FAIRE does not rely on the use of antibodies or enzymes, and is based on differences in
crosslinking efficiencies between DNA and nucleosomes or sequence-specific DNA-binding
proteins. DNA in nucleosome depleted regions of chromatin (for example through the
activity of a sequence-specific regulatory factor) is much less efficiently crosslinked to
protein12. DNA not crosslinked to protein will segregate to the aqueous phase during
phenol-chloroform extraction. In contrast, DNA covalently linked to proteins will
demonstrate hydrophilic properties, and will become trapped between the organic and
aqueous phase. To perform FAIRE (Figure 1), cells or dissociated tissues are cross-linked
briefly with formaldehyde, lysed, and sonicated. Sheared chromatin is then subjected to
phenol/chloroform extraction. The DNA in the aqueous phase is then purified and assayed.
FAIRE-enriched chromatin is detected using one of several quantitative approaches. Options
include quantitative amplification by PCR (FAIRE-qPCR)13, hybridization to a tiling DNA
microarray (FAIRE-chip)11,13, or sequencing via next-generation sequencing technologies
(FAIRE-seq)13,16. Due to declining costs of sequencing and higher quality and resolution of
sequencing-based data, FAIRE-seq has now nearly fully supplanted FAIRE-chip and
FAIRE-qPCR, especially for larger genomes, but also for smaller genomes through
multiplexing. Analysis by next-generation sequencing requires alignment of high-quality
reads to a reference genome (e.g. Bowtie19) followed by detection of regions of significant
enrichment (we recommend ZINBA20). Bowtie and ZINBA are both freely available.
Applications
Our lab has used FAIRE extensively to characterize active regulatory elements of several
human cell lines as part of the ENCODE consortium21, as well as different cell, tissue, and
tumor samples from humans, mice, and other eukaryotes. FAIRE has been used to create
catalogs of regulatory elements in normal or diseased cells13,14,16, narrow the search space
for causal sequence variants in human disease13,22, and understand the interactions between
transcription factors and chromatin remodeling23,24. When coupled with high-throughput
sequencing, FAIRE can also be used to identify both large- and small-scale structural
variations such as copy number variants (CNV)20.
Comparison with other methods
We have previously shown that regions in the yeast genome enriched by FAIRE were anti-
correlated with occupancy of histones H3 and H410, and that FAIRE regions encompass
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promoters, enhancers, insulators, and other regulatory elements, most of which are also
captured by DNase I hypersensitivity assays
10,12–14,16. An in-depth comparison between
regulatory elements captured by FAIRE, DNase I hypersensitivity, and ChIP-seq found that
while a large set of elements were identified by all methods, each assay also identified a
unique set of features16. FAIRE was able to detect some distal regulatory elements, such as
transcriptional enhancers, that DNase-seq could not, whereas DNase-seq identified some
promoters that FAIRE did not.
Advantages of FAIRE
Antibody and enzyme independency: In contrast to ChIP, which is highly subject to
antibody reliability and variability issues25, FAIRE offers the consistency of a chemical
based isolation. Moreover, FAIRE does not require enzymes, such as DNase or MNase,
which are commonly used in analogous methods for detecting nucleosome-free regions.
Avoiding the optimization and extra steps necessary for enzymatic processing or
immunoprecipitations eliminates a major source of variation, and thus makes it a much more
reliable and robust method.
Enhancer detection: As described in Comparison with other methods and in Song et
al16, FAIRE may identify additional transcriptional enhancers and other distal regulatory
elements in comparison to other methods such as DNase-seq.
Sequenced input control not required: As discussed in Rashid et al20, a sequenced input
control is not required for proper analysis of FAIRE-enriched regions. This reduces next-
generation sequencing costs as well as the cost of reagents.
Applicability to tissue samples: Since FAIRE does not require a single-cell suspension or
nuclear isolation, it is easily adapted for use on tissue samples. The only additional step
needed is pulverization of frozen tissue into a coarse powder prior to fixation.
Limitations
Promoter detection—As described in Comparison with other methods and in Song et
al16, other methods, such as DNase-seq, may be better at identifying nucleosome-depleted
promoters of highly expressed genes.
Analysis—As noted below in Experimental design, although FAIRE is relatively
straightforward experimentally, an extensive amount of computational processing and
analysis are required for comprehensive interpretation of genome-wide results. Groups
without access to bioinformatics specialists and computers with sufficient memory,
computing power, and storage capacity may experience challenges in interpreting their
results. Quantification of FAIRE signal by qPCR or microarrays may be more
straightforward.
Absence of transcription factor footprinting—Transcription factor motifs can be
identified in regions of open chromatin identified by FAIRE. However, the higher resolution
and increased signal-to-noise of DNase-seq permits detection of specific transcription factor
footprints in very deeply sequenced data1.
Low signal-to-noise—Relative to ChIP-seq or DNase-seq experiments, FAIRE has a
lower signal-to-noise ratio. Therefore, the sites detected by FAIRE can, at times, be only
marginally enriched above the background signal. This leads to a reduced confidence in the
sites identified. This effect can be exacerbated when using non-sequencing based detection
methods. Consequently, primer and array design as well as the selection of control regions
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are critical. Despite the low signal-to-noise ratio, we note that FAIRE is remarkably
reproducible from experiment to experiment.
Fixation variation among tissues—Fixation efficiency can vary drastically due to
many reasons, including differences in cellularity, permeability, purity, fat content, and
surface area. Although dissociation by pulverization seems to make fixation slightly more
consistent compared to mincing or other methods, this variability can still lead to
inconsistent results; optimization is thus recommended.
Experimental design
Replicates—Studies utilizing FAIRE, like many other genome-wide assays, should
include biological replicates. This entails the use of multiple independently grown batches of
cells or tissues treated in the same fashion. Several methods have been developed for the
assessment of concordance among replicates, such as Irreproducible Discovery Rate
(IDR)26, which is currently employed by the ENCODE consortium. Methods like IDR often
require a ranked set of statistically enriched regions, which can be obtained by most peak-
calling algorithms, including ZINBA20 (see Analysis below).
Control sample—For sequencing-based detection of FAIRE enrichment, we have found
that a control sample, such as genomic or input DNA, while always better to have, is not
strictly necessary for samples that have been sequenced to sufficient depth and coverage20.
When detecting enrichment by qPCR or tiling DNA microarrays, a genomic or input DNA
sample is necessary for use as a reference.
Analysis—Although FAIRE is a relatively straightforward experimental protocol that can
be completed in three days, extensive computational processing and analysis are required for
interpretation of the results. This includes quality assessment of the sequencing library and
the sequencing reactions themselves, reference genome alignment, detection of enrichment,
and assessment of replicate concordance. We recommend a combination of the FASTX-
Toolkit (http://hannonlab.cshl.edu/fastx_toolkit/) and TagDust27 for quality control of the
sequencing reactions and libraries, respectively. Although we typically use Bowtie19 for
reference genome alignment, other similar algorithms such as BWA28 are equally suitable.
To detect regions of significant FAIRE enrichment (“peaks”), we found that methods such
as MACS29 and Fseq30, though commonly used successfully for ChIP-seq or DNase-seq
data, do not perform well on FAIRE-seq data, likely due to its relatively lower inherent
signal-to-noise ratio. We thus developed a novel statistical algorithm called ZINBA20. The
regions identified by ZINBA can then be used to assess concordance among replicates using
algorithms such as IDR26. If possible, the data should be compared to existing maps of open
chromatin, such as DNase-seq and FAIRE-seq data made available by the ENCODE
consortium21, or with gene expression data. FAIRE enrichment at gene promoters is
strongly linked to gene expression. Therefore, strong FAIRE enrichment is expected around
genes known to be highly expressed. A large fraction (~30–50%) of the regions enriched by
FAIRE are in intergenic regions of the genome Typically only ~5–15% of all FAIRE sites
are at proximal promoters13,16. To determine if an experiment was successful, we often
examine the pattern from a locus on human chromosome 19 that produces a remarkably
consistent level of FAIRE enrichment across cell types (see Anticipated Results).
Detection method—In cases where a reference genome assembly is available, FAIRE
coupled with high-throughput sequencing is likely the most cost-effective option, especially
if multiplexing is applicable. In smaller eukaryotes or for very targeted experiments,
detection by microarray or quantitative PCR may be preferable, but array and primer design
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will play a key role in the overall success of the experiment (see FAIRE-chip Microarray
design and FAIRE-qPCR Primer design below).
Fixation—The most common reason for a failed FAIRE experiment is under-fixation of the
cells. We have found that for a majority of mammalian cells in culture, fixation for five
minutes with formaldehyde is both adequate and ideal. The protocol below includes
quantification of both input control and FAIRE DNA, and we describe a diagnostic for
determining if the sample has not been fixed sufficiently. For tissues, samples must first be
pulverized into a course powder and then fixed for 7–9 minutes. The adequacy of fixation
will depend heavily on the tissue size and composition and thus may need to be optimized.
Other techniques or adaptations for fixation may be required for plants or fungi, such as
significantly increased fixation time10 or modified fixation solutions31. For lipid-laden cells,
it may be beneficial to perform both fixation and cell lysis (to extract nuclei) prior to
attempting to harvest the cells, as outlined below in step 1B.
Sonication—Sonication parameters must be optimized for each experiment due to
variation in cell number, composition, sonicator and probe type, and fixation. In Figure 2,
we present a representative agarose gel that provides examples of over-, under-, and
sufficiently sonicated chromatin. Ideally, chromatin is sheared to a range of about 150–750
bp with an average fragment length around 300–400 bp. Sonication yielding average
fragment sizes smaller than this can result in reduced detection of highly nucleosome-
depleted regions. High molecular weight bands may be visible especially when beginning
with frozen tissue, but their presence in lieu of a distribution of smaller fragments is
indicative of under-sonication or poor cell lysis.
FAIRE-chip Microarray design—The two main considerations for microarray design
are the resolution (or spacing) of the probes throughout the genome and the set of genomic
loci covered by the probes. Resolution is the genomic distance from one probe to the next
and must be sufficiently dense to capture the physiologically relevant size of the DNA
fragments recovered by FAIRE (~200 bp). Probe spacing should allow a minimum of 3
probes per FAIRE DNA fragment or ~65 bp resolution. The set of genomic regions
represented on the array is important as it provides a relative interpretation of the results.
This is due to all the measurements being expressed as a ratio of the FAIRE signal over a
reference sample, which is normalized by centering based on the mean ratio. The majority of
probes should span regions that correspond to background (not open) chromatin. There are a
number of published protocols that address specific aspects of array design and include
recommendations for reliable detection32–41.
FAIRE-qPCR Primer design—When detecting FAIRE enrichment via quantitative PCR,
careful consideration of experimental design will maximize the chance of success. In
addition to the methodology for quantification of the results, selection of an appropriate set
of control regions and locations of primers play an important role in calculating relative
enrichment. This is often difficult due to the lack of a priori knowledge of both true FAIRE-
positive and -negative sites for most cell or tissue types or growth conditions. The data made
available by the ENCODE consortium may be helpful in this regard21. We often employ a
tiling approach for detection of open chromatin sites using qPCR, such that primer pairs are
designed so the amplicons are either directly overlapping or closely spaced across the
assayed genomic regions. As a control, we recommend using primer sets that flank the
regions isolated by FAIRE. Since primers spanning or near the edges of sonication
breakpoints of FAIRE fragments are unlikely to properly amplify, primer pairs should be
designed such that they amplify 60–100 bp within the center of the region of interest. Primer
sets should be validated on a dilution series of input DNA to confirm consistent and
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proportionate amplification characteristics. For these and other reasons, FAIRE-chip and
FAIRE-seq are strongly preferred over FAIRE-qPCR.
Materials
Reagents
• Formaldehyde 37% w/v (Fisher Scientific F79-500). CAUTION: Formaldehyde is
toxic by inhalation or if swallowed; is irritating to the skin, eyes, and respiratory
system; and may be carcinogenic. Formaldehyde should be used with appropriate
safety measures such as protective gloves, glasses, clothing, and sufficient
ventilation. All waste should be handled according to hazardous waste regulations.
• 2.5 M glycine (Fisher Scientific BP381-500).
• 1 × Dulbecco’s phosphate buffered saline (Cellgro 21-031).
• Tris-HCl pH 8.0 (Fisher Scientific BP152-500).
• Tris HCl pH 7.4 (Fisher Scientific BP152-500).
• Triton X-100 (Fisher Scientific BP151-500).
• Sodium dodecyl sulfate (Fisher Scientific BP166-500).
• NaCl (Mallinkrodt 7581).
• EDTA (Fisher Scientific BP120-500).
• KCl (Fisher Scientific BP366-500)
• NP-40 (Sigma I8896-100)
• Sucrose (Gibco 15503-014)
• Protease inhibitors (Roche 11836153001)
• DNase-free RNaseA (10ug/uL) (Roche 11119915001).
• Proteinase K (20mg/mL) (Roche 03115836001).
• Phenol/Chloroform/Isoamyl Alcohol 25:24:1 (Sigma P3803). CAUTION: Phenol/
chloroform is harmful if swallowed or in contact with skin, causes severe skin
burns and eye damage, is fatal if inhaled, and is potentially carcinogenic. It should
be used with appropriate safety measures such as protective gloves, glasses,
clothing, and sufficient ventilation. All waste should be handled according to
hazardous waste regulations.
• Chloroform/Isoamyl Alcohol 24:1 (Sigma C0549). CAUTION: Chloroform/
isoamyl alcohol is harmful if swallowed, causes skin and eye irritation, and is
potentially carcinogenic. It should be used with appropriate safety measures such as
protective gloves, glasses, clothing, and sufficient ventilation. All waste should be
handled according to hazardous waste regulations.
• 95% ethanol (Decon 2801)
• Glycogen (20mg/mL) (Roche 901393).
• 3 M sodium acetate pH 5.2 (Mallinkrodt 7364).
• 70% ethanol (ice cold, diluted from 95% ethanol)
• Double-distilled water
Simon et al. Page 6













• Lysis buffer A (see REAGENT SETUP)
• Lysis buffer B (see REAGENT SETUP)
• Sucrose pad (see REAGENT SETUP)
• SYBR green master mix (Applied Biosystems 4309155)
Equipment
Lab equipment
• Cell scrapers (such as Corning 3008)
• Liquid nitrogen and appropriate container
• Tissue pulverizer (such as Biospec 59012N)
• Nutator (such as BD/Clay Adams 421105)
• Temperature controlled swinging bucket centrifuge (such as Fisher Scientific
Accuspin 1R)
• Dounce (such as Kimble-Chase 885300-0000)
• Bead-beater (Biospec Mini-BeadBeater-8)
• Tubes with metal beads, 2.38 mm (MoBio 13117-50). CRITICAL STEP: We have
found that the specified metal beads dissociate tissues or cell clumps better than
other materials
• Sonicator (such as Branson Sonifier 450D equipped with microtip)
• Zymo-I spin columns (C1003-250)
• Zymo DNA binding buffer (D4004-1-L)
• Zymo Wash buffer (D4003-2-4)
• Fluorometer with DNA quantification reagents and standards (such as Invitrogen
Q32866) or NanoDrop ND-1000. Quantification of DNA is necessary, and a
fluorescence-based system is recommended as it is much more accurate.
• MicroAmp™ Optical 96-Well Reaction Plate (applied Biosystems 4306737).
Computer and software
• A computer with at least 8 GB RAM and 100 GB hard drive, preferably with a
UNIX subsystem, such as Mac OS X or LINUX, and multiple processing cores.
• Bowtie19, for reference genome alignment, ZINBA20 for peak-calling, and
TagDust27 and FASTX-Toolkit (http://hannonlab.cshl.edu/fastx_toolkit/) for
quality control. All are freely available and run easily in a command-line context.
Reagent Setup
• Lysis buffer A (10 mM Tris-HCl pH 8.0, 2% Triton X-100, 1% SDS, 100 mM
NaCl, 1 mM EDTA). Store at 4°C for a maximum of 6 months.
• Lysis buffer B (10 mM Tris-HCl pH 7.4, 15 mM NaCl, 60 mM KCl, 1 mM EDTA,
0.1% NP-40, 5% sucrose, 1X protease inhibitors). Prepare stock solution excluding
protease inhibitors and store at 4 °C for a maximum of 6 months.
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• Sucrose pad (10mM Tris pH 7.4, 15 mM NaCl, 60 mM KCl, 10% sucrose, 1X
protease inhibitors). Prepare stock solution excluding protease inhibitors, sterile-
filter, and store at 4 °C for a maximum of 6 months.
Equipment Setup
• Tissue preparation: To pulverize tissues, pre-chill both the mortar and the pestle
of a tissue pulverizer in liquid nitrogen. Tissues should be pulverized until a coarse
powder is achieved, with a granularity similar to that of cornmeal or granulated
sugar. Samples should only be allowed to begin to thaw after pulverization is
completed and before PBS is added, since the PBS will otherwise freeze.
• Cell dissociation: For dissociation of cells and tissues we use the Mini-
BeadBeater-8, set to homogenize. Although settings will depend on cell or tissue
type, we begin with five 2-minute cycles at 4 °C, allowing the sample to cool on ice
for 2 minutes between each cycle. We have found that the specified metal beads
dissociate tissues or cell clumps better than other materials
• Sonication: We typically use a Branson Sonifier 450D, equipped with a microtip.
Although the settings will depend on cell or tissue type, growth conditions, and
crosslinking, we begin with 30% amplitude and 6 cycles (where each cycle has a
1.0 s burst followed by a 0.5 s pause and a total length of 30 s) and allow the
sample to cool in an ice-water bath during and/or between cycles
Procedure
Formaldehyde crosslinking and cell lysis. TIMING Day 1, 4–6 hours
1 For formaldehyde-crosslinking of cells, chose one of the following three
procedures depending on whether you are using (A) typical adherent or
suspension cells, (B) adherent lipid-laden cells such as adipocytes (or if a bead-
beater is unavailable), or (C) frozen tissues. The procedure described in C has
been tested on human and mouse samples. Alterations such as increased fixation
length may be necessary for non-mammalian eukaryotes such as plants or fungi;
we recommend reviewing existing publications performing chromatin
immunoprecipitations for such necessary adaptations. Other modifications may
also be necessary, such as those made for pancreatic islets42.
A. For typical adherent or suspension cells:
i. Culture 1 × 106 – 5 × 107 cells for each experiment. If
available, 1 × 107 cells is ideal for most applications.
ii. Add 37% formaldehyde directly to the media to a final
concentration of 1%.
iii. Fix for 5 minutes while rocking at room temperature (25
°C).
iv. Add 2.5 M glycine to a final concentration of 125 mM to
quench formaldehyde.
v. Rock an additional 5 minutes at room temperature.
vi. Scrape cells if needed and pool in 50mL conical tubes
vii. Spin at 300–500g for 5 minutes at 4 °C to collect fixed
cells. Decant or pipette supernatant into formaldehyde
waste.
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viii. Wash pellet with 10 mL 1× PBS.
ix. Repeat steps 1Avii – viii twice for a total of three washes.
During the final wash, transfer cells in PBS to 15 mL
conical tubes.
x. Flash-freeze the fixed cell pellets in liquid nitrogen.
PAUSE POINT: Once cells have been frozen, they can be
stored at −80 °C indefinitely.
xi. Resuspend fixed cells in 1 mL cold lysis buffer A and
transfer to the tubes containing the metal beads.
xii. Dissociate and lyse cells by bead beating (see Equipment
Setup). For most cell and tissue types, five two-minute
cycles followed by two minutes of rest (on ice) is
sufficient, but additional cycles may be required.
CRITICAL STEP: This step must be performed in a 4 °C
room.
xiii. Transfer lysate to 15 mL conical tube. Wash the beads
that are left behind with an additional 1 mL of cold lysis
buffer A. Add this wash to the 15 mL tube for a final
lysate volume of 2 mL.
B. For adherent lipid-laden cells (or if bead-beater is unavailable):
i. Begin with 1 × 106 – 5 × 107 cells for each experiment. If
available, 1 × 107 cells is ideal for most applications.
ii. Add 37% formaldehyde directly to the media to a final
concentration of 1%.
iii. Fix for 5 minutes while rocking at room temperature.
iv. Add 2.5 M glycine to a final concentration of 125 mM to
quench formaldehyde.
v. Rock an additional 5 minutes at room temperature.
vi. Pipette and remove the formaldehyde, glycine, and media
mixture without disturbing the cells.
vii. Scrape cells in 7 mL lysis buffer B added directly to the
plate. Multiple plates can be pooled by scraping cells
from each plate in the same 7mL of lysis buffer B such
that the final volume does not exceed 7mL.
viii. Dounce cells with 5–10 smooth strokes using a tight
fitting pestle.
ix. Transfer to a 15 mL conical tube and add 2 mL sucrose
pad slowly to the bottom of the tube using a Pasteur pipet.
x. Centrifuge at 2,100g for 20–25 minutes at 4 °C to collect
nuclei
xi. Aspirate to remove supernatant.
xii. Resuspend nuclear pellet in 2 mL lysis buffer A.
C. For frozen tissues
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i. Begin with 20 – 200 mg frozen tissue.
ii. Pulverize frozen tissue into a coarse powder (see
Equipment Setup). Allow sample to begin to thaw.
CRITICAL STEP: Pulverization of the tissue to a coarse
powder, rather than mincing or douncing, allows for a
more uniform fixation.
iii. Add 5 mL PBS to resuspend powder, avoiding freezing of
PBS. Transfer to 15 mL conical tube.
iv. Wash pulverizer mortar and pestle with additional 5 mL
PBS and add to conical tube for a total volume of 10 mL.
v. Add 37% formaldehyde to a final concentration of 1%.
vi. Fix for 7–9 minutes while rocking at room temperature.
vii. Add 2.5 M glycine to a final concentration of 125 mM to
quench formaldehyde.
viii. Rock an additional 5 minutes at room temperature.
ix. Spin at 300–500g for 5 minutes at 4 °C to collect fixed
tissue. Pipette supernatant into formaldehyde waste.
x. Wash pellet with 10 mL 1× PBS.
xi. Repeat steps 1Cvii – viii twice for a total of three washes.
During the final wash, transfer tissue in PBS to 15 mL
conical tubes.
xii. Flash-freeze fixed tissue in liquid nitrogen. PAUSE
POINT: Once tissues have been frozen, they can be stored
at −80°C indefinitely.
xiii. Resuspend fixed tissue in 1 mL cold lysis buffer A and
transfer to the tubes containing the metal beads.
xiv. Dissociate tissue and lyse cells by bead beating (see
Equipment Setup). For most cell and tissue types, five
two-minute cycles followed by two minutes of rest (on
ice) is sufficient, but additional cycles may be required.
CRITICAL STEP: This must be performed in a 4°C
room.
xv. Transfer lysate to 15 mL conical tube. Wash the beads
that are left behind with an additional 1 mL of cold lysis
buffer A. Add this wash to the 15 mL tube for a final
lysate volume of 2 mL. Note that some clumps or
cloudiness may remain, especially if the tissue was
particularly vascular.
Sonication. TIMING: Day 1, 1–2 hours
2 Sonicate cell lysate to achieve an average DNA fragment size of approximately
300–400 bp. For most cell and tissue types, six 30-second cycles with 1s bursts
followed by 0.5s rest at 30% amplitude using the Branson Sonifier 450D is
sufficient, but optimization may be required for some cell or tissue types or for
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other sonicators. Samples should be allowed to cool in an ice-water bath during
and/or between sonication cycles or for at least 1–2 minutes.
CRITICAL STEP: Foaming should be avoided, as this likely decreases sonication
efficiency. If foaming occurs, let sample settle on ice until bubbles have subsided or
centrifuge briefly and gently resuspend all material. Probe positioning heavily influences
both sonication efficiency and whether or not sample will foam. In most cases, the probe
should be placed in the center of the tube approximately one-quarter to one-half an inch
from the bottom.
Preparation of input control DNA. Day 1, 1.5 hours and overnight incubation
3 Remove a 100 uL aliquot of cell lysate to check efficiency of sonication.
Remaining lysate can be stored temporarily at 4 °C.
4 Centrifuge aliquot of lysate at 15,000 – 20,000g for 5 minutes at 4 °C to pellet
cell debris.
5 Transfer supernatant to fresh 1.5 mL tube
6 Add 1uL DNase-free RNaseA. Incubate for 30 minutes at 37°C. CRITICAL
STEP: RNaseA must be DNase-free.
7 Add 1ul proteinase K, incubate at 55°C for 1 hr, then incubate overnight at 65°C
to reverse crosslinks.
Purification and assessment of input control DNA. Day 2, 3–4 hours
8 If needed, collect sample by brief centrifugation in a microfuge or tabletop
centrifuge. Add 200 uL 10 mM Tris-HCl pH 7.4 to a final volume of 300 uL and
ensure all materials are fully resuspended.
9 Add 300 uL phenol/chloroform/isoamyl alcohol. CAUTION: See REAGENTS
for precautions when using phenol and chloroform
10 Vortex for 10 seconds. Centrifuge at 12,000g for 5 minutes in a tabletop
centrifuge
11 Transfer aqueous (top) layer to a fresh 1.5 mL tube
12 To ensure complete retrieval of aqueous material, add 150 uL 10 mM Tris-HCl
pH 7.4 to the tube containing the interphase and organic layer
13 Vortex for 10 seconds. Centrifuge at 12,000g for 5 minutes in a tabletop
centrifuge.
14 Transfer aqueous (top) layer and combine with previously isolated aqueous
material.
15 Add 1 volume phenol/chloroform/isoamyl alcohol. CAUTION: See
REAGENTS for precautions when using phenol and chloroform
16 Vortex for 10 seconds. Centrifuge at 12,000g for 5 minutes in a tabletop
centrifuge
17 Transfer aqueous (top) layer to a fresh 1.5 mL tube
18 Add 200 ul chloroform/isoamyl alcohol to remove traces of phenol. CAUTION:
See REAGENTS for precautions when using phenol and chloroform.
19 Vortex for 10 seconds. Centrifuge at 12,000g for 5 minutes in a tabletop
centrifuge
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20 Transfer aqueous layer to a fresh 1.5 mL tube.
21 Add 1/10 volume 3 M Sodium Acetate (pH 5.2), 2 volumes 95% ethanol, and 1
uL 20 mg/mL glycogen
22 Incubate at −80 °C for 30 min or longer. PAUSE POINT: Precipitations can be
left at −80 °C overnight or longer.
23 Centrifuge at 12,000g for 15 minutes at 4 °C to precipitate DNA
24 Carefully aspirate supernatant without disturbing DNA pellet.
25 Wash pellet with 500 uL ice cold 70% ethanol
26 Centrifuge at 12,000g for 5 minutes at 4°C
27 Carefully aspirate supernatant without disturbing DNA pellet.
28 Dry pellet with a speedvac or by leaving tubes open for 10–20 minutes, then
resuspend pellet in 20uL 10mM Tris-HCl pH 7.4. CRITICAL STEP: Remaining
traces of ethanol can affect downstream steps. Make sure pellets are completely
dry before resuspending.
29 Quantify 1 uL of input control DNA with fluorometer or NanoDrop. We
recommend fluorometry-based quantification due to its increased accuracy. For
experiments beginning with around 1 × 107 cells or 150 mg of tissue, input
control yields should be around 50–100 ng/uL with a total volume of 20 uL.
TROUBLESHOOTING.
30 Run 500 ng or half of input control DNA on 1% agarose gel and visualize with
ethidium bromide. CRITICAL STEP: Sufficient sonication has been achieved if
fragments range in size from 100 bp and 1,000 bp, with an approximate average
fragment length of between 200bp and 500bp. If only a large molecular weight
band is detected or if the average fragment size is significantly larger than 500
bp, additional rounds of sonication are necessary. Retrieve lysate from 4 °C
storage and repeat steps 2–31 until this optimal range of fragment sizes has been
achieved. PAUSE POINT: Input control DNA can be frozen and stored
indefinitely at −80 °C. Cell lysates can be stored at 4 °C for up to several days,
or frozen and stored for several weeks at −80 °C. TROUBLESHOOTING
Preparation of FAIRE DNA. Day 2, 3–4 hours and overnight incubation
31 Aliquot remaining cell lysate into 1.5 mL tubes each with no more than 500 uL.
One aliquot can be stored at −80 °C indefinitely as backup.
32 Centrifuge aliquots of lysate at 15,000 – 20,000g for 5 minutes at 4 °C to pellet
cell debris.
33 Transfer supernatants to fresh 1.5 mL tubes
34 Add 1 volume phenol/chloroform/isoamyl alcohol to each aliquot. CAUTION:
See REAGENTS for precautions when using phenol and chloroform
35 Vortex each tube for 10 seconds. Centrifuge at 12,000g for 5 minutes in a
tabletop centrifuge
36 Transfer aqueous (top) layers to fresh 1.5 mL tubes. TROUBLESHOOTING.
37 To ensure complete retrieval of aqueous material, add 150 uL 10 mM Tris-HCl
pH 7.4 to the tubes containing the interphase and organic layers
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38 Vortex each tube for 10 seconds. Centrifuge at 12,000g for 5 minutes in a
tabletop centrifuge
39 Transfer aqueous (top) layers and combine with previously isolated aqueous
material.
40 Add 1 volume phenol/chloroform/isoamyl alcohol to each tube. CAUTION: See
REAGENTS for precautions when using phenol and chloroform
41 Vortex each tube for 10 seconds. Centrifuge at 12,000g for 5 minutes in a
tabletop centrifuge
42 Transfer aqueous (top) layers to fresh 1.5mL tubes
43 Add 200ul chloroform/isoamyl alcohol to each tube to remove traces of phenol.
CAUTION: See REAGENTS for precautions when using phenol and
chloroform.
44 Vortex for 10 seconds. Centrifuge at 12,000g for 5 minutes in a tabletop
centrifuge
45 Transfer aqueous layer to fresh 1.5mL tubes.
46 Add 1/10 volume 3 M Sodium Acetate (pH 5.2), 2 volumes 95% ethanol, and 1
uL 20 mg/mL glycogen to each tube
47 Incubate at −80 °C for 30 min or longer. PAUSE POINT: Precipitations can be
left at −80 °C overnight or longer.
48 Centrifuge at 12,000g for 15 minutes at 4°C to precipitate DNA
49 Carefully aspirate supernatants without disturbing DNA pellets.
50 Wash pellets with 500 uL ice cold 70% ethanol
51 Centrifuge at 12,000g for 5 minutes at 4°C
52 Carefully aspirate supernatants without disturbing DNA pellet.
53 Dry pellets with a SpeedVac or by leaving tubes open for 10–20 minutes, then
resuspend pellet in 50uL 10mM Tris-HCl pH 7.4. CRITICAL STEP: Remaining
traces of ethanol can affect downstream steps. Make sure pellets are completely
dry before resuspending.
54 Add 1 uL DNase-free RNaseA. Incubate for 30 minutes at 37 °C. CRITICAL
STEP: RNaseA must be DNase-free.
55 Add 1 ul proteinase K, incubate at 55 °C for 1 hr, then incubate overnight at 65
°C to reverse any DNA-DNA crosslinks.
Purification and assessment of FAIRE DNA. Day 3, 1 hour
56 If needed, collect sample with brief centrifugation in a microfuge or tabletop
centrifuge
57 Purify with Zymo-I spin columns using 2 volumes of DNA binding buffer and
using 200 uL wash buffer for each washing step. Elute twice with 10 uL 10mM
Tris-HCl pH 7.4, allowing buffer to sit on the column at room temperature for
1–2 minutes.
58 Quantify 1uL of FAIRE DNA with fluorometer or NanoDrop. We recommend
fluorometry-based quantification due to its increased accuracy. For experiments
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beginning with around 1 × 107 cells or 150 mg of tissue, FAIRE yields should
be around 6–12 ng/uL with a total volume of 20 uL.
CRITICAL STEP: To test if the FAIRE yield is within an acceptable range, we recommend
dividing the total FAIRE yield (in nanograms) by the volume of cell lysate used for FAIRE
(in uL, the number of lysate aliquots multiplied by the aliquot volume). A similar value
should be calculated for the input control (total yield in nanograms over lysate aliquot
volume). The volume-normalized ratio of FAIRE DNA isolated with respect to input control
DNA isolated should not exceed 5% and will ideally fall in the 1–3% range. A retrieval ratio
significantly higher than 5% is often indicative of under-fixation and may predict
experimental failure due to poor signal enrichment.
PAUSE POINT: FAIRE DNA can be frozen and stored indefinitely at −80°C.
TROUBLESHOOTING.
Detection of FAIRE enrichment and basic data analysis
59 For detection of FAIRE enrichment, one of three procedures can be used
depending on whether you are utilizing next-generation sequencing (FAIRE-
seq)13,16 (A), tiling DNA microarrays (FAIRE-chip)11,13 (B), or quantitative
PCR (FAIRE-qPCR)13 (C). The procedure described in A has been tested on the
Illumina sequencing platform and thus optimization may be required for other
platforms. The procedure described in B has been tested on multiple human
tiling DNA microarray platforms including Nimblegen (Roche) and Agilent, but
optimization may be required for certain platforms or array types.
A. Detection and analysis by next-generation sequencing – FAIRE-seq
i. Prepare sequencing libraries using manufacturer’s
protocols. We recommend beginning with 100–200 ng of
FAIRE DNA. We typically incorporate two rounds of
purification with Agencourt AMPure XP beads prior to 18
cycles of amplification by PCR, and size-select the final
library to 200–500 bp, avoiding adapter bands, which
typically run under 100 bp. CRITICAL STEP: We have
found that sufficient depth and coverage on the human
genome is typically achieved with no less than 3 × 107
aligned reads.
ii. Remove sequencing reads with significant adapter
contribution using an algorithm such as TagDust27. We
typically set the False Discovery Rate (FDR) parameter to
0.001. CRITICAL STEP: For clean libraries, an average
of about 0.1–0.2% of reads are filtered at this step.
Significantly higher fractions (>10%) are indicative of
poor library quality.
iii. Assess sequencing quality, including confidence scores
and nucleotide distributions, using algorithms such as
those in the FASTX-Toolkit (http://hannonlab.cshl.edu/
fastx_toolkit/). CRITICAL STEP: It is important that a
relatively even nucleotide distribution is observed for all
nucleotides across every read sequence. An over-
representation of “N”, abundance of a specific sequence,
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or wide variability in sequence quality is indicative of
poor library complexity or sequencing errors.
iv. Align high-quality reads to reference genome using an
algorithm such as Bowtie19 with default parameters,
except restrict the maximum number of allowable
alignments to 4 and force Bowtie to pick the highest-
scoring alignment when multiple possibilities exist. For
most genomes and experiments, ~75–85% of sequencing
reads are successfully aligned.
v. Create files for visualization and detect regions of
significant enrichment with respect to local background
using ZINBA20. TROUBLESHOOTING.
vi. Assess cross-replicate correlation using an algorithm such
as IDR26.
B. Detection by tiling DNA microarrays – FAIRE-chip.
i. Amplify FAIRE and input control DNA using ligation-
mediated PCR (LM-PCR)32,43
ii. Follow manufacturer’s recommended protocols and refer
to Lee et al (2006)32 for sample labeling, hybridization
and image acquisition procedures.
iii. For dual channel platforms (such as NimbleGen) data for
each probe on the microarray is expressed as a log2 ratio,
which is normalized by calculating the Z-score for each
probe.
iv. Identify regions enriched by FAIRE; this can be
accomplished using most peak-finding algorithms used
for ChIP-chip. We recommend ChIPOTle44 or Mixer45. If
applicable, the window size should be sufficiently large
enough to contain approximately 10 probes and the step
size should be set to equal the resolution of the
microarray.
C. Detection by quantitative PCR – FAIRE-qPCR
i. In each well of a MicroAmp™ Optical 96-Well reaction
plate, add 12.5 uL of 2X SYBR green master mix, 5 uL of
DNA (2.5 to 25 ng/uL, ideal is 5 ng/uL), 1 uL primers (20
uM concentration) and 6.5 uL dH20.
ii. Seal plate with optical adhesive film
iii. Cycling parameters will vary, but typically 50 °C for 2
min, 95 °C for 10 min and the 40 cycles of 95 °C for 15
sec and 60 °C for 1 min and finally 60 °C for 1 min.
iv. Calculate the relative enrichment for each amplicon using
the comparative Ct method46, such that a ratio is
calculated for the signal from the FAIRE sample relative
to the signal from input control DNA.
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Day 1: Steps 1–8 (approximately 7–8 hours and overnight incubation)
Day 2: Steps 9–31 (approximately 3–4 hours)
Day 2: Steps 32–56 (approximately 3–4 hours and overnight incubation)
Day 3: Steps 57–59 (approximately 1 hour)
Troubleshooting
Troubleshooting advice can be found in Table 1.
Anticipated Results
Visualize FAIRE-seq or FAIRE-chip data in a browser such as the UCSC Genome
Browser47. For data from human cells or tissues, we expect to see enrichment similar to that
presented in Figure 3a. This genomic locus on chromosome 19 contains several genes that
each contain a nucleosome-depleted promoter detectable in nearly every cell or tissue type
assayed to date, including all Tier-1 and Tier-2 cell types assayed by ENCODE (a total of 19
cell types to date)21. Additionally, there are some cell-type-selective regions of open
chromatin, such as the region immediately upstream of CNOT3, which is selective for
embryonic stem cells and HepG2. The aggregated FAIRE signal around all transcription
start sites (TSS) ranked by their gene expression should be similar to that presented in
Figure 3b, showing a strong nucleosome-free region approximately 125 bp upstream of TSS
and depletion (representing a well-positioned nucleosome) immediately downstream of TSS.
The average signal across all genes is presented in Figure 3c. The number of regions of the
genome enriched by FAIRE should be approximately 100,000 in any given cell or tissue
type. FAIRE additionally detects distal regulatory regions, such as those marked by CTCF
(Figure 3d).
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Example timeline for FAIRE protocol. Steps are grouped by day for the typical timeline, but
utilizing Pause Points will extend the duration.
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Representative gel image showing varying degrees of sonication. NIH3T3 cells were fixed
and lysed as described above. Chromatin was then sheared by sonication for 0, 2, 4, 6, 8, and
10 cycles using the parameters outlined in step 2A. After clearing cell debris, crosslinks
were reversed, and purified DNA was run on a 1% agarose gel. A 100 bp ladder (lane
marked M) is included for reference. The target range for fragment sizes is shown. Six
cycles yields an ideal distribution of fragment lengths; fewer than six cycles of sonication is
insufficient for solubilization and shearing of chromatin, whereas sonication beyond six
cycles leads to oversonication. A high molecular weight band is slightly visible and marked
with an asterisk.
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Expected results from FAIRE-seq experiments. A. Genomic locus residing on chromosome
19 as visualized with the UCSC Genome Browser47 shows consistent FAIRE enrichment at
transcriptional start sites (TSS) across seven ENCODE cell lines16. Data are presented as
number of aligned, in silico extended reads per base, on a scale of 0 to 50 reads. Pink
coloring atop tall peaks of enrichment represent where signal exceeded this range. B.
Heatmap of normalized GM12878 FAIRE signal ±3kb around TSS ranked by gene
expression in GM12878 cells. Color was assigned on a log2 scale of −6 (background) to −2
(enriched). C. Average GM12878 FAIRE signal ±3kb around TSS across all genes.
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Enrichment peaks around −125bp. D. Average GM12878 FAIRE signal ±3kb around
GM12878 CTCF sites, representing a class of distal regulatory elements.
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Table 1
Troubleshooting
Step Problem Possible reason Solution
29 Low input control yield Low starting cell number Start experiment with more cells or larger tissue (step 1)
Poor cell lysis Vary dissociation and cell lysis conditions (step 1)
30 Sheared chromatin has
incorrect average fragment
length
Solution foamed Make sure sonicator tip is centered and located ¼ to ½ an inch from
bottom of tube and that sample has been cooled in ice-water bath (step 2)
Under-sonicated Increase number of sonication cycles (step 2)
Under-fixation Insufficiently crosslinked chromatin will lead to production of very small
fragments. Increase fixation time or vary fixation conditions (step 1)
36 Aqueous layer is cloudy Phenol may be overloaded
due to high cell number
Start experiment with fewer cells or smaller tissue (step 1)
58 High DNA yield Under-fixation Insufficiently crosslinked chromatin will lead to high DNA yields with
respect to input control. Increase fixation time or vary fixation conditions
(step 1)
58 Low DNA yield Low starting cell number Start experiment with more cells or larger tissue (step 1)
Over-fixation Over-crosslinking will reduce recovery of nucleosome-depleted regions.
Reduce fixation time or vary fixation conditions (step 1)
59 Poor signal-to-noise Under-fixation Insufficiently crosslinked chromatin will lead to decreased enrichment by
FAIRE. Increase fixation time or vary fixation conditions (step 1)
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